Abstract:Abstract Drug design targeting protein–protein interactions (PPIs) associated with the development of diseases has been one of the most important therapeutic strategies. Besides interrupting the PPIs with PPI inhibitors/blockers, increasing evidence shows that stabilizing the interaction between two interacting proteins may also benefit the therapy, such as the development of various types of molecular glues/stabilizers that mostly work by stabilizing the two interacting proteins to regulate the downstream biological effects. However, characterizing the stabilization effect of a stabilizer is usually hard or too complicated for traditional experiments since it involves ternary interactions [protein–protein–stabilizer (PPS) interaction]. Thus, developing reliable computational strategies will facilitate the discovery/design of molecular glues or PPI stabilizers. Here, by fully analyzing the energetic features of the binary interactions in the PPS ternary complex, we systematically investigated the performance of molecular mechanics Poisson-Boltzmann surface area (MM/PBSA) and molecular mechanics generalized Born surface area (MM/GBSA) methods on characterizing the stabilization effects of stabilizers in 14-3-3 systems. The results show that both MM/PBSA and MM/GBSA are powerful tools in distinguishing the stabilizers from the decoys (with area under the curves of 0.90–0.93 for all tested cases) and are reasonable for ranking protein–peptide interactions in the presence or absence of stabilizers as well (with the average Pearson correlation coefficient of ~0.6 at a relatively high dielectric constant for both methods). Moreover, to give a detailed picture of the stabilization effects, the stabilization mechanism is also analyzed from the structural and energetic points of view for individual systems containing strong or weak stabilizers. This study demonstrates a potential strategy to accelerate the discovery of PPI stabilizers.

14‐3‐3 Protein‐Protein Interactions: From Mechanistic Understanding to their Small‐molecule Stabilization

Modulators of 14-3-3 Protein–Protein Interactions

Small-Molecule Stabilization of Protein-Protein Interactions: An Underestimated Concept in Drug Discovery?

Design Of Drug-Like Protein-Protein Interaction Stabilizers Guided By Chelation-Controlled Bioactive Conformation Stabilization

What Makes a Good Protein–Protein Interaction Stabilizer: Analysis and Application of the Dual-Binding Mechanism

Targeting Protein-Protein Interaction by Small Molecules

Structure-Based Optimization of Covalent, Small-Molecule Stabilizers of the 14-3-3σ/ERα Protein-Protein Interaction from Nonselective Fragments

Cooperative stabilisation of 14-3-3σ protein-protein interactions via covalent protein modification

Functional mapping of the 14-3-3 hub protein as a guide to design 14-3-3 molecular glues

Small molecules, big targets: drug discovery faces the protein–protein interaction challenge

Fragment-based Differential Targeting of PPI Stabilizer Interfaces

Characterizing the stabilization effects of stabilizers in protein–protein systems with end-point binding free energy calculations

Characterizing the protein–protein interaction between MDM2 and 14-3-3σ; proof of concept for small molecule stabilization

Emerging Roles of Allosteric Modulators in the Regulation of Protein‐protein Interactions (ppis): A New Paradigm for PPI Drug Discovery

Allosteric Modulators of Protein-Protein Interactions (PPIs).

Recent advances in the development of protein–protein interactions modulators: mechanisms and clinical trials

New insights into protein–protein interaction modulators in drug discovery and therapeutic advance

Small molecules targeting protein‒protein interactions for cancer therapy

State-of-the-art strategies for targeting protein-protein interactions by small-molecule inhibitors

Selectivity via Cooperativity: Preferential Stabilization of the p65/14-3-3 Interaction with Semisynthetic Natural Products

Rational Design of Peptide-Based Inhibitors Disrupting Protein-Protein Interactions